Table 1.
Coefficient | Model 0a | Model 1b | Model 2c | Model 3d | |||||||
|
OR (95% CI) | P values | OR (95% CI) | P values | OR (95% CI) | P values | OR (95% CI) | P values | |||
Intercept | 0.14 (0.12-0.17) | <.001 | 3.49 (1.76-6.92) | <.001 | 5.18 (2.41-11.13) | <.001 | 359.87 (55.38-2338.31) | <.001 | |||
Day of measurement | —e | — | 0.97 (0.96-0.98) | <.001 | 0.97 (0.96-0.98) | <.001 | 0.97 (0.96-0.99) | <.001 | |||
Self-rated health | — | — | 0.44 (0.37-0.52) | <.001 | 0.40 (0.32-0.49) | <.001 | 0.80 (0.64-1.01) | <.001 | |||
Initial occurrence of Symptoms (yes) | — | — | 9.28 (6.06- 14.22) | <.001 | 13.95 (6.20-31.37) | <.001 | 5.97 (3.67-9.72) | <.001 | |||
General and unspecified (present) | — | — | — | — | — | — | 3.33 (1.92-5.56) | <.001 | |||
Eye (present) | — | — | — | — | — | — | 5.56 (2.08-12.29) | <.001 | |||
Cardiovascular (present) | — | — | — | — | — | — | 8.33 (2.70-25.00) | <.001 | |||
Musculoskeletal (present) | — | — | — | — | — | — | 5.26 (3.44-8.33) | <.001 | |||
Skin (present) | — | — | — | — | — | — | 4.76 (2.04-11.11) | <.001 |
aσ2=3.29; τ00=0.18ID; Bayesian information criterion=1568.02; intraclass correlation coefficient=0.05; N=48 (2016 observations).
bσ2=3.29; τ00=0.26ID; Bayesian information criterion=1306.17; intraclass correlation coefficient=0.07; N=48 (2016 observations).
cσ2=3.29; τ00=0.40Intercept; τ11=0.03 (participant-rated health) and 3.26 (first-time appearance of symptoms); ρ01=–0.65 and –0.06; Bayesian information criterion=1328.20; intraclass correlation coefficient=0.13; N=48 (2016 observations).
dσ2=3.29; τ00=1.14Intercept; τ11=1.53 (general and unspecified); ρ01=–0.89ID; Bayesian information criterion=1134.82; intraclass correlation coefficient=0.13; N=48 (2016 observations).
eNot applicable.